Diarrhoeagenic infections, commonly treated with β-lactam antibiotics, contribute to antibiotic resistance - a pressing public health concern. Rapid monitoring of pathogen antibiotic resistance is vital to combat antimicrobial spread. Current bacterial diagnosis methods identify pathogens or determine antibiotic resistance separately, necessitating multiple assays. There is an urgent need for tools that simultaneously identify infectious agents and their antibiotic resistance at the point of care (POC). We developed an integrated electrochemical chip-based biosensor for detecting enteropathogenic E. coli. Leveraging an antibody against the virulence marker EspB, the dual-channel chip facilitated electrochemical impedance spectroscopy-based detection of EspB antigen (sensitivity of 10 ng/mL) and EspB-expressing bacteria. For β-lactam resistance profiling, a second channel enabled differential-pulse voltammetric measurement of hydrolyzed nitrocefin, a β-lactam analogue, demonstrating sensitive detection of the antibiotic resistance marker, β-lactamase at concentrations as low as 1 ng/mL. The integrated electrochemical biosensor successfully achieved simultaneous, rapid detection of double positive EspB- and β-lactamase-expressing bacteria, promoting advancements in POC clinical diagnosis.
Read full abstract